Globavir Biosciences Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Globavir Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011698
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Globavir Biosciences Inc (Globavir) is a specialty biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. Through Globavir’s Drug Discovery Platform (GDDP), it generates a wide range of small molecule candidates for the treatment of cancer and infectious diseases. The company’s lead product GBV006, is a potent anti-infective for Ebola, development of dengue diagnostics and small molecue drugs to treat cancer and infection diseases, develops therapeutics for infectious diseases and oncology and diagnostic for infection diseases, dengue virus and respiratory syncytial virus (RSV). It also offers products which include PanGlob, MulGlob and DenGlo for accurate diagnostics. It has research collaborations with companies like BioManguinhos, and Sorrento Therapeutics. The company operates across the US. Globavir is headquartered in Los Altos, California, US.

Globavir Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Globavir Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Globavir Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Globavir Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Globavir Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Globavir Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Globavir Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Globavir Biosciences Secures USD4 Million in Venture Funding 10
Partnerships 11
Globavir Enters into Co-Development Agreement with Biomanguinhos 11
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 12
Globavir Enters into Licensing Agreement with Stanford University 13
Globavir Biosciences Inc – Key Competitors 14
Globavir Biosciences Inc – Key Employees 15
Globavir Biosciences Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Globavir Biosciences Inc, Medical Equipment, Key Facts 2
Globavir Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Globavir Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Globavir Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Globavir Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Globavir Biosciences Inc, Deals By Market, 2011 to YTD 2017 8
Globavir Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Globavir Biosciences Secures USD4 Million in Venture Funding 10
Globavir Enters into Co-Development Agreement with Biomanguinhos 11
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 12
Globavir Enters into Licensing Agreement with Stanford University 13
Globavir Biosciences Inc, Key Competitors 14
Globavir Biosciences Inc, Key Employees 15

★海外企業調査レポート[Globavir Biosciences Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fujisoft Inc (9749):企業の財務・戦略的SWOT分析
    Fujisoft Inc (9749) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Inova Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include QUANTA Flash used for semi-quantitative determination of aut …
  • FortisBC Inc:企業の戦略的SWOT分析
    FortisBC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Federal Grid Company of Unified Energy System (FEES):企業の財務・戦略的SWOT分析
    Federal Grid Company of Unified Energy System (FEES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Veolia Environnement SA (VIE)-エネルギー分野:企業M&A・提携分析
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • AmSurg Corp (EVHC):製薬・医療:M&Aディール及び事業提携情報
    Summary AmSurg Corp (AmSurg) is a healthcare service provider that develops, acquires and operates surgery centers. The company is a surgery center management and development company that manages hospitals and health systems. It provides strategic and operational management of surgery centers that i …
  • Viridian Energy Supply Ltd.:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • The Hongkong and Shanghai Banking Corp Ltd:企業の戦略的SWOT分析
    The Hongkong and Shanghai Banking Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • MOL Hungarian Oil and Gas Plc (MOL):企業の財務・戦略的SWOT分析
    MOL Hungarian Oil and Gas Plc (MOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sirtex Medical Ltd (SRX):医療機器:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • The Scripps Research Institute-医療機器分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • Nacional Financiera S.N.C.:企業の戦略・SWOT・財務情報
    Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report Summary Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Citic Resources Holdings Limited
    Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Prescient Therapeutics Ltd (PTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the …
  • Gelita AG:企業の戦略・SWOT・財務情報
    Gelita AG - Strategy, SWOT and Corporate Finance Report Summary Gelita AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Knoll, Inc.:戦略・SWOT・企業財務分析
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CIMB Group Holdings Berhad:戦略・SWOT・企業財務分析
    CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆